All lobbying filings

Manatt, Phelps, and Phillips

Manatt, Phelps, and Phillips filed a Q2 report for Denali Therapeutics on July 10, 2025, reporting $67,500 in lobbying income.

Lobbying for Denali Therapeutics · Biopharmaceutical Company

As filed: MANATT, PHELPS, AND PHILLIPS for DENALI THERAPEUTICS.

All filings by Manatt, Phelps, and Phillips · Everything Denali Therapeutics has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 10, 2025

Income

$67,500

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbying activity 1

Health Issues

Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.